GSK plc (the `Company')
Transaction notification
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Emma Walmsley
b) Position/status Chief Executive
Officer
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 9 (partnership
shares)
£14.9465 9 (matching shares)
d) Aggregated
information
Aggregated 18 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Julie Brown
b) Position/status Chief Financial
Officer
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
£14.9465
Price
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name James Ford
b) Position/status SVP and Group
General Counsel,
Legal and Compliance
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Sally Jackson
b) Position/status SVP, Global
Communications and
CEO Office
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name David Redfern
b) Position/status President, Corporate
Development
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Regis Simard
b) Position/status President, Global
Supply Chain
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Philip Thomson
b) Position/status President, Global
Affairs
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Deborah Waterhouse
b) Position/status CEO, ViiV Healthcare
and President,
Global Health, GSK
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
1. Details of
PDMR/person closely
associated with
them (`PCA')
a) Name Victoria Whyte
b) Position/status Company Secretary
c) Initial Initial notification
notification/
amendment
2. Details of the
issuer, emission
allowance market
participant,
auction platform,
auctioneer or
auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the
transaction(s):
section to be
repeated for (i)
each type of
instrument; (ii)
each type of
transaction; (iii)
each date; and (iv)
each place where
transaction(s) has
been conducted
a) Description of the Ordinary shares of
financial 31 ¼ pence each
instrument (`Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the Acquisition of
transaction Ordinary Shares
under the Company's
Share Reward Plan
c) Price(s) and Price(s) Volume(s)
volume(s)
£14.9465 8 (partnership
shares)
£14.9465 8 (matching shares)
d) Aggregated
information
Aggregated 16 Ordinary Shares
volume
Price £14.9465
e) Date of the 2025-06-10
transaction
f) Place of the London Stock
transaction Exchange (XLON)
This information was brought to you by Cision http://news.cision.com